As of Aug 26
| +0.04 / +0.76%|
The 1 analysts offering 12-month price forecasts for China Cord Blood Corp have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.50. The median estimate represents a +22.87% increase from the last price of 5.29.
The current consensus among 1 polled investment analysts is to Hold stock in China Cord Blood Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.